CARAT offers fellowships for a training course on CAR T cell manufacturing

The EU-funded project CARAT “Chimeric Antigen Receptors (CARs) for Advanced Therapies” aims to develop a new, comprehensive platform for innovative cell manufacturing technologies. In order to accomplish the goal of providing a safe, automated, and cost-efficient manufacture of effective CAR T cells for personalised cancer therapies, CARAT, consisting of eight partners from four different European countries, was initiated. Within the framework of CARAT, a training course on GMP compliant CAR T cell manufacturing will be organised. This training event will take place on December 11-15, 2017 at Miltenyi Biotec’s headquarters in Bergisch Gladbach, Germany.

The CARAT training fellowship

The fellowship is tailored to experienced scientists in the cellular and gene therapy field, who expect to initiate clinical applications in the near future. The 5-day training course will transmit know-how on GMP compliant CAR T cell manufacturing, with a focus on practical, regulatory and scientific matters, to five selected trainees. Objectives of the training event include an introduction to cell separation technology, a deep overview of the T cell transduction (TCT) process on the automated CliniMACS Prodigy® cell processing platform, and an active exchange about regulatory requirements including clinical trial design and approval processes. After the course, each CARAT trainee will be prepared to independently perform the automated manufacture of cellular products as well as manage logistical aspects such as GMP compliance and adherence to monitoring guidelines.

Application

Applicants from EU Member States and Associated Countries are encouraged to participate and submit their applications by May 31, 2017.

Read more on how to apply for the CARAT training fellowship: http://carat-horizon2020.eu/news-events/carat-training-fellowship

Eurice supports the consortium as partner in all aspects of project and IP management safeguarding smooth project implementation as well as efficient exploitation and valorisation of research outcomes. Moreover, Eurice will assist the consortium in effective project communications to ensure a continuous and broad outreach to relevant stakeholder groups.